Pathway analysis from RNA-seq data shows several pathways, including metabolic and immune processes, were affected by siRNA-mediated k.d. of YBEY. Finally, we show that YBEY expression is higher in early-stage tumor tissues than adjacent normal tissues in TCGA breast cancer database. Here, YBEY is linked to neoplasm.